BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34610949)

  • 1. Friedreich's ataxia-associated childhood hypertrophic cardiomyopathy: a national cohort study.
    Norrish G; Rance T; Montanes E; Field E; Brown E; Bhole V; Stuart G; Uzun O; McLeod KA; Ilina M; Adwani S; Daubeney P; Delle Donne G; Linter K; Jones CB; Bharucha T; Cervi E; Kaski JP
    Arch Dis Child; 2022 May; 107(5):450-455. PubMed ID: 34610949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Obesity With Adverse Long-term Outcomes in Hypertrophic Cardiomyopathy.
    Fumagalli C; Maurizi N; Day SM; Ashley EA; Michels M; Colan SD; Jacoby D; Marchionni N; Vincent-Tompkins J; Ho CY; Olivotto I;
    JAMA Cardiol; 2020 Jan; 5(1):65-72. PubMed ID: 31693057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical presentation and survival of childhood hypertrophic cardiomyopathy: a retrospective study in United Kingdom.
    Norrish G; Field E; Mcleod K; Ilina M; Stuart G; Bhole V; Uzun O; Brown E; Daubeney PEF; Lota A; Linter K; Mathur S; Bharucha T; Kok KL; Adwani S; Jones CB; Reinhardt Z; Kaski JP
    Eur Heart J; 2019 Mar; 40(12):986-993. PubMed ID: 30535072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The longitudinal course of cardiomyopathy in Friedreich's ataxia during childhood.
    Kipps A; Alexander M; Colan SD; Gauvreau K; Smoot L; Crawford L; Darras BT; Blume ED
    Pediatr Cardiol; 2009 Apr; 30(3):306-10. PubMed ID: 18716706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modes of death and clinical outcomes in adult patients with hypertrophic cardiomyopathy in Thailand.
    Songsirisuk N; Kittipibul V; Methachittiphan N; Charoenattasil V; Zungsontiporn N; Spanuchart I; Buppajarntham S; Mankongpaisarnrung C; Satitthummanid S; Srimahachota S; Chattranukulchai P; Boonyaratavej Songmuang S; Puwanant S
    BMC Cardiovasc Disord; 2019 Jan; 19(1):1. PubMed ID: 30606129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Friedreich's Ataxia: a review from a cardiology perspective.
    Bourke T; Keane D
    Ir J Med Sci; 2011 Dec; 180(4):799-805. PubMed ID: 21822977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Prevalence and Association of Exercise Test Abnormalities With Sudden Cardiac Death and Transplant-Free Survival in Childhood Hypertrophic Cardiomyopathy.
    Conway J; Min S; Villa C; Weintraub RG; Nakano S; Godown J; Tatangelo M; Armstrong K; Richmond M; Kaufman B; Lal AK; Balaji S; Power A; Baez Hernandez N; Gardin L; Kantor PF; Parent JJ; Aziz PF; Jefferies JL; Dragulescu A; Jeewa A; Benson L; Russell MW; Whitehill R; Rossano J; Howard T; Mital S
    Circulation; 2023 Feb; 147(9):718-727. PubMed ID: 36335467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children.
    Decker JA; Rossano JW; Smith EO; Cannon B; Clunie SK; Gates C; Jefferies JL; Kim JJ; Price JF; Dreyer WJ; Towbin JA; Denfield SW
    J Am Coll Cardiol; 2009 Jul; 54(3):250-4. PubMed ID: 19589438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External validation of the HCM Risk-Kids model for predicting sudden cardiac death in childhood hypertrophic cardiomyopathy.
    Norrish G; Qu C; Field E; Cervi E; Khraiche D; Klaassen S; Ojala TH; Sinagra G; Yamazawa H; Marrone C; Popoiu A; Centeno F; Schouvey S; Olivotto I; Day SM; Colan S; Rossano J; Wittekind SG; Saberi S; Russell M; Helms A; Ingles J; Semsarian C; Elliott PM; Ho CY; Omar RZ; Kaski JP
    Eur J Prev Cardiol; 2022 Mar; 29(4):678-686. PubMed ID: 34718528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of Long-Term Outcome in Children with Hypertrophic Cardiomyopathy.
    Ziółkowska L; Turska-Kmieć A; Petryka J; Kawalec W
    Pediatr Cardiol; 2016 Mar; 37(3):448-58. PubMed ID: 26526335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical scenarios of hypertrophic cardiomyopathy-related mortality: Relevance of age and stage of disease at presentation.
    Zampieri M; Salvi S; Fumagalli C; Argirò A; Zocchi C; Del Franco A; Iannaccone G; Giovani S; Ferrantini C; Palinkas ED; Cappelli F; Olivotto I
    Int J Cardiol; 2023 Mar; 374():65-72. PubMed ID: 36621577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between aetiology and left ventricular systolic dysfunction in hypertrophic cardiomyopathy.
    Rosmini S; Biagini E; O'Mahony C; Bulluck H; Ruozi N; Lopes LR; Guttmann O; Reant P; Quarta CC; Pantazis A; Tome-Esteban M; Mckenna WJ; Rapezzi C; Elliott PM
    Heart; 2017 Feb; 103(4):300-306. PubMed ID: 27798053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of hypertrophic cardiomyopathy in Japanese children: a retrospective cohort study.
    Mori H; Yoshikawa T; Kimura H; Ono H; Kato H; Ono Y; Nii M; Shindo T; Inuzuka R; Horigome H; Miura M; Hirono K; Kobayashi T; Kogaki S; Furutani Y; Nakanishi T
    Heart Vessels; 2022 Jun; 37(6):1075-1084. PubMed ID: 34799788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the new risk prediction model (HCM Risk-SCD) and classic risk factors for sudden death in patients with hypertrophic cardiomyopathy and defibrillator.
    Ruiz-Salas A; García-Pinilla JM; Cabrera-Bueno F; Fernández-Pastor J; Peña-Hernández J; Medina-Palomo C; Barrera-Cordero A; De Teresa E; Alzueta J
    Europace; 2016 May; 18(5):773-7. PubMed ID: 25855675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes in adult athletes with hypertrophic cardiomyopathy: a 7-year follow-up study.
    Pelliccia A; Caselli S; Pelliccia M; Musumeci MB; Lemme E; Di Paolo FM; Maestrini V; Russo D; Limite L; Borrazzo C; Autore C
    Br J Sports Med; 2020 Aug; 54(16):1008-1012. PubMed ID: 32532845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy.
    Adabag AS; Casey SA; Kuskowski MA; Zenovich AG; Maron BJ
    J Am Coll Cardiol; 2005 Mar; 45(5):697-704. PubMed ID: 15734613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics of hypertrophic cardiomyopathy in children: An 8-year single center experience.
    Tunca Sahin G; Ozgur S; Kafali HC; Sevinc Sengul F; Haydin S; Guzeltas A; Ergul Y
    Pediatr Int; 2021 Jan; 63(1):37-45. PubMed ID: 32682351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Septal myectomy for hypertrophic obstructive cardiomyopathy in Friedreich's ataxia.
    Anderson HN; Burkhart HM; Johnson JN
    Cardiol Young; 2016 Jan; 26(1):175-8. PubMed ID: 25687499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Implication of First-Degree Atrioventricular Block in Patients With Hypertrophic Cardiomyopathy.
    Higuchi S; Minami Y; Shoda M; Shirotani S; Saito C; Haruki S; Gotou M; Yagishita D; Ejima K; Hagiwara N
    J Am Heart Assoc; 2020 Mar; 9(6):e015064. PubMed ID: 32146896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population.
    Maron BJ; Olivotto I; Spirito P; Casey SA; Bellone P; Gohman TE; Graham KJ; Burton DA; Cecchi F
    Circulation; 2000 Aug; 102(8):858-64. PubMed ID: 10952953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.